Full Name
Alan Prem Kumar
Variants
Kumar, A.P.
Kumar, A.
Prem Kumar, A.
Kumar, Alan Prem Rem
 
 
 
Email
apkumar@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Department:  DEAN'S OFFICE (MEDICINE)
Subject:  Humans

Results 1-20 of 20 (Search time: 0.051 seconds).

Issue DateTitleAuthor(s)
12016ANXA1 inhibits miRNA-196a in a negative feedback loop through NF-kB and C-Myc to reduce breast cancer proliferationYuan, Y ; Anbalagan, D; Lee, L.H; Samy, R.P ; Shanmugam, M.K ; Kumar, A.P ; Sethi, G ; Lobie, P.E ; Lim, L.H.K 
22017Art therapy and music reminiscence activity in the prevention of cognitive decline: Study protocol for a randomized controlled trialMahendran, R ; Rawtaer, I ; Fam, J ; Wong, J ; Kumar, A.P ; Gandhi, M ; Jing, K.X; Feng, L ; Kua, E.H 
32017Epigenetic reprogramming converts human Wharton's jelly mesenchymal stem cells into functional cardiomyocytes by differential regulation of Wnt mediatorsBhuvanalakshmi, G; Arfuso, F; Kumar, A.P ; Dharmarajan, A; Warrier, S
41-Jan-2022Exosomes as Promising Nanostructures in Diabetes Mellitus: From Insulin Sensitivity to Ameliorating Diabetic ComplicationsAshrafizadeh, M; Kumar, AP ; Aref, AR; Zarrabi, A; Mostafavi, E
52015Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkersLi F. ; Shanmugam M.K. ; Siveen K.S. ; Wang F. ; Ong T.H.; Loo S.Y. ; Swamy M.M.M.; Mandal S.; Kumar A.P. ; Goh B.C. ; Kundu T.; Ahn K.S.; Wang L.Z. ; Hui K.M. ; Sethi G. 
62016Gelsolin-Cu/ZnSOD interaction alters intracellular reactive oxygen species levels to promote cancer cell invasionTochhawng, L ; Deng, S ; Pugalenthi, G; Kumar, A.P ; Lim, K.H ; Yang, H ; Hooi, S.C ; Goh, Y.C; Maciver, S.K; Pervaiz, S ; Yap, C.T 
71-Dec-2022Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for interventionMirzaei, S; Paskeh, MDA; Okina, E ; Gholami, MH; Hushmandi, K; Hashemi, M; Kalu, A; Zarrabi, A; Nabavi, N; Rabiee, N; Sharifi, E; Karimi-Maleh, H; Ashrafizadeh, M; Kumar, AP ; Wang, Y
81-Dec-2023PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancerGlaviano, A; Foo, ASC; Lam, HY ; Yap, KCH ; Jacot, W; Jones, RH; Eng, H ; Nair, MG; Makvandi, P; Geoerger, B; Kulke, MH; Baird, RD; Prabhu, JS; Carbone, D; Pecoraro, C; Teh, DBL; Sethi, G ; Cavalieri, V; Lin, KH; Javidi-Sharifi, NR; Toska, E; Davids, MS; Brown, JR; Diana, P; Stebbing, J; Fruman, DA; Kumar, AP 
9Nov-2017PPARγ Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers.Chen, Luxi ; Yuan, Yi; Kar, Shreya; Kanchi, Madhu M ; Arora, Suruchi; Kim, Ji E; Koh, Pei F ; Yousef, Einas; Samy, Ramar P ; Shanmugam, Muthu K ; Tuan Z ; Shin, Sung W; Arfuso, Frank; Shen, Han M ; Yang, Henry; Goh, Boon C ; Park, Joo I; Gaboury, Louis; Lobie, Peter E ; Sethi, Gautam ; Lim, Lina HK ; Kumar, Alan P 
102018Pro-apoptotic and anti-cancer properties of diosgenin: A comprehensive and critical reviewSethi, G ; Shanmugam, M.K ; Warrier, S; Merarchi, M; Arfuso, F; Kumar, A.P ; Bishayee, A
112018Role of RNF20 in cancer development and progression – a comprehensive reviewSethi, G ; Shanmugam, M.K ; Arfuso, F; Kumar, A.P 
122017Short-chain fatty acid receptors inhibit invasive phenotypes in breast cancer cellsThirunavukkarasan M.; Wang C. ; Rao A. ; Hind T.; Teo Y.R.; Siddiquee A.A.-M. ; Goghari M.A.I.; Kumar A.P. ; Herr D.R. 
132014SPHK1 regulates proliferation and survival responses in triplenegative breast cancerDatta, A ; Loo, S.Y ; Huang, B ; Wong, L ; Tan, S.S.L ; Tan, T.Z ; Lee, S.-C ; Thiery, J.P ; Lim, Y.C ; Yong, W.P ; Lam, Y ; Kumar, A.P ; Yap, C.T 
142017SREBP-1c as a molecular bridge between lipogenesis and cell cycle progression of clear cell renal carcinomaSethi, G ; Shanmugam, M.K ; Kumar, A.P 
151-Dec-2022Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic responseAshrafizadeh, M; Paskeh, MDA; Mirzaei, S; Gholami, MH; Zarrabi, A; Hashemi, F; Hushmandi, K; Hashemi, M; Nabavi, N; Crea, F; Ren, J; Klionsky, DJ; Kumar, AP ; Wang, Y
162017The role of resveratrol in cancer therapyKo, J.-H; Sethi, G ; Um, J.-Y; Shanmugam, M.K ; Arfuso, F; Kumar, A.P ; Bishayee, A; Ahn, K.S
172014Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse modelSiveen, K.S ; Mustafa, N ; Li, F ; Kannaiyan, R; Ahn, K.S; Kumar, A.P ; Chng, W.-J ; Sethi, G 
182018TIPE family of proteins and its implications in different chronic diseasesBordoloi D.; Banik K.; Shabnam B.; Padmavathi G.; Monisha J.; Arfuso F.; Dharmarajan A.; Mao X., Lim L.H.K. ; Wang L. ; Fan L. ; Hui K.M. ; Kumar A.P. ; Sethi G. ; Kunnumakkara A.B.
192014?-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse modelSiveen K.S. ; Ahn K.S.; Ong T.H.; Shanmugam M.K. ; Li F. ; Yap W.N.; Kumar A.P. ; Fong C.W.; Tergaonkar V. ; Hui K.M. ; Sethi G. 
202017ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activatorJahn, A; Rane, G ; Paszkowski-Rogacz, M; Sayols, S; Bluhm, A; Han, C.-T; Draškovič, I; Londoño-Vallejo, J.A; Kumar, A.P ; Buchholz, F; Butter, F; Kappei, D